Member Info for elrico

Ha ha ha ha… sorry, I couldn’t help myself. :)

Clio,

Think of as a topic of interest that keeps us yapping for little while longer. As far as I’m concerned the pictures speak for themselves. For all I know I may wake up balder next week, or a ponytail under each armpit. :)

Aqua,

Note the time stamp. Two weeks! :)

Clio,

It is more about the speed at which the coat grew back, not the fact it did.

I am sure some peeps will find some of my waffle mildly amusing. But, it is perhaps a little more serious for those of us with long-established sunroofs. I have transformational development to impart - for your amusement only.

Also, comment on the SP action.

https://lemminginvestor.substack.com/p/shock-and-awe

A dam fine resource if I do say so myself. :)
https://lemminginvestor.substack.com/

Accountable for what, precisely?

"My next order is due on the 26th, would you like me to post my order number?"

Only if you have paid for it! :)

mol,

I suspect I will be at the back of a long queue of people who need to apologise to you for attempting to build a business. I'll be a long way behind SA and SOH. Do you expect freemans from them?

Aqua, Mol,

You are both missing the original points I made in my article; https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-004

But first, nowhere did I or anybody make a claim to BB-Biont being an SBTX product. My focus was the SkinBiotix "technology platform," suggesting I/we may have placed too much focus on the antiaging lysate, a singular market (antiaging). I believe SkinBiotix technology has a much broader application than just antiaging.

I also reminded readers of enhancements during scaleup, which could fall within the BBB technical sheet (provided in the article) where Sederma make specific claims.

I did not mean Croda would sell the lysate to Sederma competitors; that would not make sense. I was referring to the skincare market product portfolio. They are herd-like in their direction/fashion.

I would envisage Sederma gaining more cosmetic/skincare clients. This would be a natural occurrence with a superior product, technology, etc.

Clio,

Toyin has explained it very well.

The only other point I would make is this. Investors should not think of the SkinBiotix platform like they may with OPTI's LP-LDL or SlimBiome as the "Intel inside." These are products with their own patents/IP.

Croda manufactures the lysate developed by SkinBiotix, which is then supplied to Sederma as a raw active ingredient.

We know Sederma's rivals will catch on eventually because the whole industry moves in the same direction as new products and technology are developed. Geoff Bell offered some insight into this in Manchester.

Disco,

If, and I stress if...I am not "barking up the wrong tree" there was the first skincare cream launched in March.
https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-004

Belgrano, Clio, Toyin,

Thanks for your support.

I'm unsure of Oleric specifics (filtered), but to be fair to the fellow, He will have an ally in my wife. She often argues I do talk a lot of rubbish, usually after consuming too much trooper or sleep-talking.

Have a good weekend, all.

Erland,

When was the HSR tip? I know where 60% plus volume has come from over the last two weeks.

HSR have made similar predictions for OPTI, Christmas 2017, then Easter, the Christmas 2018 and then Easter. Still waiting! The rest is history!

200k on top of your regular accumulation of stock, Sir!

Vote Desantis! :)

Phat,

There you go again, making threats. A man of your stature would need to wear my stilettos to reach my ferret's kneecaps. So, please, less of the keyboard bravado. You previously claimed to know my address, and you were due at a branch of Specsavers near me. You have my mobile number. I am happy to meet and share a coffee and chew the fat.

For the record, the "insults", as you describe, were northern humour - an effort to add colour to your single topic comment on cash burn. It's tedious because it's been done before and answered before, not just by this little Hobbit, but by Stuart.

Any idea what this means.... :-)

Now Open Orphan has Completed its name change to hVivo #HVO, why not catch up with recent events?

There is a huge amount of free resources and research material available on
https://smallcompanychampion.substack.com #HVO is the most popular Company on our site.

Phat once again am twisting facts to justify him bailing and try to save face with F&M blindly following him, no doubt after he has finished selling.

There are a number of exceptional in the accounts. Moreover, there was a £400k inventory for AxisBiotix which is sold at a c76% margin. In addition, SA was clear as he could be during the chat with me. Currently, there are no plans to raise to keep the lights of and bolt the door to prevent Phat entering. Croda recurring revenues land in H1, but we know there is more in the pipe.

Get your eyes tested, Phat. I suggest Vision express because Specsavers haven’t provided you with the full-Phat service you deserve. :)

There’s good article about probiotics worth a read, even better, it features LPLDL.

https://www.nutritionaloutlook.com/view/probiotic-benefits-extend-beyond-the-gut